Literature DB >> 30272320

MicroRNA‑mRNA integrated analysis based on a case of well‑differentiated thyroid cancer with both metastasis and metastatic recurrence.

Yun-Jie Zhang1, Yu-Shui Ma2, Qing Xia3, Fei Yu4, Zhong-Wei Lv5, Cheng-You Jia5, Xiao-Xin Jiang3, Liang Zhang3, Yun-Chao Shao3, Wen-Ting Xie5, Gai-Xia Lu5, Xia-Qing Yv5, Peng Zhong5, Da Fu6, Xiao-Feng Wang3.   

Abstract

The incidence of well‑differentiated thyroid cancer (WDTC) is rapidly increasing. Poor survival follows distant metastasis (DM) and recurrence. In the present study, we aimed to analyze the expression alterations in different stages of WDTC and the regulatory mechanism of DM and the recurrence of DM. A male patient diagnosed with follicular thyroid cancer and distant metastasis in the eleventh thoracic vertebrae received total thyroidectomy and the removal of a metastatic lesion. A local relapse was found in the vertebrae after four‑time iodine‑131 treatment. We performed mRNA and microRNA microarray on the paracancerous, cancerous, metastatic and metastatic recurrent tissue. In combination with the data of The Cancer Genome Atlas (TCGA), we used bioinformatics approaches to analyze the common alterations and microRNA‑mRNA interactions among the processes of tumorigenesis and metastasis. Metastatic lesions and recurrent lesions were used to investigate the molecular mechanism of tumor evolution and recurrence in this case. A total of four mRNAs and two microRNAs were newly found to be related to patient survival in WDTC. The microRNA‑mRNA interactions were predicted for the overlapped mRNAs and microRNAs. Lineage deregulation of genes, such as C‑X‑C motif chemokine receptor 4 (CXCR4) and thyroglobulin (TG) were found from the tumorigenic stage to the metastatic stage. The ribosome pathway was highly enriched in the bone metastasis compared with the cancerous tissue. The downstreaming effects of p53 were impaired in the recurrent lesion due to deregulation of several functional genes. The integrated analysis with TCGA data indicated several prognostic markers and regulatory networks for potential treatment. Our results also provided possible molecular mechanisms in which the ribosome and p53 pathways may respectively contribute to bone metastasis and local recurrence of metastasis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30272320     DOI: 10.3892/or.2018.6739

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  4 in total

1.  Dual Regulatory Mechanisms of Expression and Mutation Involving Metabolism-Related Genes FDFT1 and UQCR5 during CLM.

Authors:  Yu-Shui Ma; Zhi-Jun Wu; Hong-Wei Zhang; Bo Cai; Tao Huang; Hui-Deng Long; Hong Xu; Yong-Zhong Zhao; Yu-Zhen Yin; Shao-Bo Xue; Liu Li; Cheng-Lin Liu; Ru-Ting Xie; Lin-Lin Tian; Ji-Bin Liu; Xu-Ming Wu; Da Fu
Journal:  Mol Ther Oncolytics       Date:  2019-05-22       Impact factor: 7.200

2.  Potential biomarkers of abnormal osseointegration of implants in type II diabetes mellitus.

Authors:  Lingxiao Wang; Zhenhua Gao; Changying Liu; Jun Li
Journal:  BMC Oral Health       Date:  2021-11-18       Impact factor: 2.757

3.  Profiling and Integrated Analysis of Differentially Expressed MicroRNAs as Novel Biomarkers of Hepatocellular Carcinoma.

Authors:  Yuwei Xie; Yixiu Wang; Weijie Xue; Hao Zou; Kun Li; Kui Liu; Wei Zhao; Chengzhan Zhu; Jingyu Cao
Journal:  Front Oncol       Date:  2022-01-31       Impact factor: 6.244

4.  MiRNA expression deregulation correlates with the Oncotype DX® DCIS score.

Authors:  Olivier Loudig; Megan I Mitchell; Iddo Z Ben-Dov; Christina Liu; Susan Fineberg
Journal:  Breast Cancer Res       Date:  2022-09-12       Impact factor: 8.408

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.